Conference abstract · 30 Aug 2016
Conference abstractPublished 23 Sep 2015
Human cannabinoid receptor CB2:Expression, functional and structural studies
National Institute on Alcoholism and Alcohol Abuse, USA
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
The human cannabinoid receptor CB2 belongs to the class A of heptahelical G protein-coupled receptors (GPCR) and is an attractive target for the development of drugs for management of pain, inflammation, osteoporosis and treatment of immunological disorders. High resolution structural studies are critical to obtain insights into the molecular mechanisms of ligand binding and activation of CB2.We developedmethods for expression in milligram quantities, purification, reconstitution in lipid bilayers and stabilization of the functional recombinant CB2 as well as efficient stable isotope labeling of CB2 by high density fermentation were developed enabling NMR studies. NMR analysis of labeled receptor reconstituted in proteoliposomes in agonist or inverse-agonist-bound form will be reported.Monoclonal antibodies wereraised against the purified CB2 and the affinity of interaction with CB2 was determined by surface plasmon resonance.Finally, we demonstrate the specific effects of lipids with negatively charged head group in activation of CB2 reconstituted in proteoliposomes as measured by an in vitro G protein activation which may have important physiological significance as manifested in natural membranes of various lipid compositions.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Mini review · 30 Dec 2023
In Rats, the Chemotherapeutic Drug Vincristine Induced Neuropathic Nociception is Suppressed When Cannabinoid CB1 and CB2 Receptors are Activated
Conference abstract · 2017
Correlation link between immune system abnormalities and cannabinoid receptors 2 (CB2) signal dysregulation in autism: novel approach in autism research and treatment
Conference abstract · Oct 2020
Cannabinoid pharmacodynamics beyound CB1 and CB2 receptors
Conference abstract · 24 Oct 2016
Tamoxifen and its derivatives bind to and act at cannabinoid receptors CB1 and CB2 with high affinity
More from this journal
The newest in Journal of Biotechnology & Biomaterials.
Editorial · 30 May 2025
Biocatalytic Conversion of Agricultural Waste into Value-Added Chemicals Using Engineered Microbial Systems
Editorial · 30 May 2025
3D Bioprinting of Vascularized Tissue Constructs Using Bioink-Embedded Endothelial Cells
Editorial · 30 May 2025
Development of Flexible Bioelectronic Interfaces for Real-Time Neural Signal Monitoring
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Biotechnology & Biomaterials
- SubjectBiochemistry & Biotechnology
- SubjectMaterials Science
- BylineArticles whose byline prints “Alexei A Yeliseev”
